US firm Palantir has officially been awarded the lucrative federated data platform deal, which is one of the biggest NHS data projects in recent years.
This week Nick Carding, Joe Talora and Annabelle Collins discuss the controversy surrounding the deal, what the risks and benefits are for the NHS and what’s next in its implementation.
Send views and questions to annabelle.collins@hsj.co.uk.
You can listen to HSJ Health Check on this page, or subscribe on Spotify, Apple Podcasts, Amazon Music and all the other popular podcast platforms.
David Hare writes how ophthalmology’s 15 per cent activity boost and reduced wait times exemplify NHS productivity, with the independent sector delivering 160 per cent more care, emphasising the potential for specialisation and patient flow improvements as vital lessons for broader health system gains
Sir Muir Gray underscores the crucial role Federated Data Platforms plays in assessing spending, outcomes, and ensuring equitable healthcare delivery
Sir Trevor Longstay regrets the passing of the old order but acknowledges the need for formal regulation of NHS managers – as long as a suitable leader can be found
This year sets the NHS one of its toughest financial challenges as pandemic cash dries up and funding shortfalls deepen.
It’s easy to get desensitised to disastrous waiting times in the NHS, but behind the numbers are real and avoidable care failures.
2022-23 was probably the worst ever winter for the NHS, after a steep collapse in performance. This year’s been a little better — new figures confirm — but how was this achieved, and what does it mean for coming months?
No comments yet